Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline-Somatic Liaison Dictates Cancer Subtypes via de novo Steroid Biosynthesis. | Cancer Discov | 2025 | 40512155 | PubTator, text mining | PubMed |
| Updates on SPOP Gene Mutations in Prostate Cancer and Computational Insights From TCGA cBioPortal Database. | Scientifica (Cairo) | 2025 | 40432836 | PubTator, text mining | PubMed |
| Development and validation of tryptophan metabolism-related risk model and molecular subtypes for predicting postoperative biochemical recurrence in prostate cancer. | Transl Androl Urol | 2025 | 40376539 | PubTator, text mining | PubMed |
| Dynamic clustering of genomics cohorts beyond race, ethnicity-and ancestry. | BMC Med Genomics | 2025 | 40375077 | PubTator, text mining | PubMed |
| A single buried cysteine acts as a hydrophobic stabilizer of a folding intermediate and transition state in the MATH domain of SPOP. | Protein Sci | 2025 | 40364751 | PubTator, text mining | PubMed |
| CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. | Nat Cancer | 2025 | 40360905 | PubTator, text mining | PubMed |
| CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancer. | Nat Cancer | 2025 | 40360904 | PubTator, text mining | PubMed |
| Somatic Tumor Next-Generation Sequencing in US Veterans With Metastatic Prostate Cancer. | JAMA Netw Open | 2025 | 40354055 | PubTator, text mining | PubMed |
| Correction: SPOP‑mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. | Mol Cancer | 2025 | 40336083 | PubTator, text mining | PubMed |
| Exome Sequencing to Identify Novel Susceptibility Genes for Nonsyndromic Split-Hand/Ft Malformation: A Report From the National Birth Defects Prevention Study. | Birth Defects Res | 2025 | 40304391 | PubTator, text mining | PubMed |
| SPOP mutations increase PARP inhibitor sensitivity via CK2/PIAS1/SPOP axis in prostate cancer. | JCI Insight | 2025 | 40260915 | PubTator, text mining | PubMed |
| The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer. | Commun Biol | 2025 | 40247055 | PubTator, text mining | PubMed |
| Computational Identification and Validation of Metabolic Cell Death-Related Prognostic Biomarkers for Personalized Treatment Strategies in Prostate Cancer. | Cell Biochem Biophys | 2025 | 40210782 | PubTator, text mining | PubMed |
| Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation. | J Med Chem | 2025 | 40202531 | PubTator, text mining | PubMed |
| Sequence rules for a long SPOP-binding degron required for protein ubiquitylation. | Biochem J | 2025 | 40178506 | PubTator, text mining | PubMed |
| Genomic features of liquid biopsies from patients with prostate cancer with and without ductal adenocarcinoma. | J Pathol Clin Res | 2025 | 40172755 | PubTator, text mining | PubMed |
| SPOP/NOLC1/B4GALT1 signaling axis enhances paclitaxel resistance in endometrial cancer by inducing O-dysglycosylation. | Oncogene | 2025 | 40097806 | PubTator, text mining | PubMed |
| [Expression and Biological Function of SPOP in Acute Myeloid Leukemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40017183 | PubTator, text mining | PubMed |
| A Multi-Omics-Based Exploration of the Predictive Role of MSMB in Prostate Cancer Recurrence: A Study Using Bayesian Inverse Convolution and 10 Machine Learning Combinations. | Biomedicines | 2025 | 40002900 | PubTator, text mining | PubMed |
| Abstracts of the 2024 Canadian Association of Medical Oncologists Annual Scientific Meeting. | Curr Oncol | 2025 | 39996905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=7